Inventor · disambiguated record
Samuel Wright
Also filed as: WRIGHT SAMUEL · WRIGHT SAMUEL D · WRIGHT SAMUEL DONALD
20 granted patents·10 pending applications·303 citations·filing 1989–2023
96Inventor score
Top patents by PatentIndex Score
30 records- 0191US9439946B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2015·Granted Sep 13, 2016·10 cites·12 claims
- 0290US11058747B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2019·Granted Jul 13, 2021·3 cites·20 claims
- 0390US5147637AMethod of inhibiting the influx of leukocytes into organs during sepsis or other traumaUNIV ROCKEFELLER·Filed 1989·Granted Sep 15, 1992·52 cites·6 claims
- 0488US8999920B2Reconstituted high density lipoprotein formulation and production method thereofWRIGHT SAMUEL·Filed 2011·Granted Apr 7, 2015·14 cites·11 claims
- 0587US10335457B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2016·Granted Jul 2, 2019·5 cites·20 claims
- 0680US6680340B2Anti-hypercholesterolemic drug combinationMERCK & CO INC·Filed 2001·Granted Jan 20, 2004·14 cites·13 claims
- 0778US6297049B1Methods and compositions for ameliorating the symptoms of sepsisSCRIPPS RESEARCH INST·Filed 2000·Granted Oct 2, 2001·8 cites·3 claims
- 0876US11723953B2Reconstituted high density lipoprotein formulation and production method thereofCSL LTD·Filed 2021·Granted Aug 15, 2023·0 cites·12 claims
- 0976US5322699ALeukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)UNIV ROCKEFELLER·Filed 1991·Granted Jun 21, 1994·41 cites·16 claims
- 1072US5928624ACompositions for neutralization of lipopolysaccharidesUNIV ROCKEFELLER·Filed 1995·Granted Jul 27, 1999·33 cites·12 claims
- 1170US6495332B2Methods and compositions for ameliorating the symptoms of sepsisSCRIPPS RESEARCH INST·Filed 2001·Granted Dec 17, 2002·3 cites·6 claims
- 1270US5730980AMethods and compositions for ameliorating the symptoms of sepsisSCRIPPS RESEARCH INST·Filed 1994·Granted Mar 24, 1998·19 cites·8 claims
- 1366US2024207357A1Reconstituted high density lipoprotein treatment of myocardial infarctionCSL LTD·Filed 2023·Application pending·0 cites
- 1464USD663119SCombined backpack and luggageWRIGHT SAMUEL·Filed 2011·Granted Jul 10, 2012·14 cites·1 claims
- 1563US5869055AAnti-inflammatory CD14 polypeptidesAMGEN INC·Filed 1995·Granted Feb 9, 1999·18 cites·14 claims
- 1661US5767243AAfamin: a human serum albumin-like proteinAMGEN INC·Filed 1997·Granted Jun 16, 1998·11 cites·10 claims
- 1761US5652352AAfamin: a human serum albumin-like geneAMGEN INC·Filed 1994·Granted Jul 29, 1997·16 cites·12 claims
- 1858US5932536ACompositions for neutralization of lipopolysaccharidesUNIV ROCKEFELLER·Filed 1994·Granted Aug 3, 1999·19 cites·38 claims
- 1956US6045795AMethods and compositions for ameliorating the symptoms of sepsisSCRIPPS RESEARCH INST·Filed 1997·Granted Apr 4, 2000·12 cites·18 claims
- 2053US5766593AAnti-inflammatory CD14 peptidesAMGEN INC·Filed 1994·Granted Jun 16, 1998·9 cites·17 claims
- 2151US2004259850A1Method for treating or preventing symptoms of hormonal variation including hot flashesFiled 2002·Application pending·0 cites
- 2250US2020038481A1Reconstituted high density lipoprotein treatment of myocardial infarctionCSL LTD·Filed 2017·Application pending·0 cites
- 2349US2004248863A1Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflamationFiled 2002·Application pending·0 cites
- 2449US2004167107A1Ppar-alpha ligands for the treatment or prevention of cachexiaFiled 2002·Application pending·0 cites
- 2546US2021269517A1Method of treating wasting disordersCSL LTD·Filed 2019·Application pending·0 cites
- 2637US5436321AAntibodies to the lipopolysaccharide bonding opsonin septinUNIV ROCKEFELLER·Filed 1991·Granted Jul 25, 1995·2 cites·7 claims
- 2736US2004115127A1Ppar-alpha-gamma ligands or agonists for the treatment of inflammationFiled 2002·Application pending·0 cites
- 2834US2004242459A1Method for treating inflammatory diseases by administering a ppar-delta agonistFiled 2002·Application pending·0 cites
- 2929US2004071633A1Method for determining efficacy of reverse cholesterol transport enhancing agentsFiled 2002·Application pending·0 cites
- 3028US2004116327A1Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaquesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →